Immunohistochemistry Can Act as a Surrogate to Aid Difficult Diagnoses of Soft Tissue Tumors
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Immunohistochemistry (IHC) offers a reliable, cost-effective alternative to genetic testing for diagnosing soft tissue tumors.
Nikon Corporation celebrates the 100th anniversary of its JOICO microscope, marking the beginning of its Healthcare Business Unit.
AI is transforming cervical cancer screening through advanced image recognition, risk prediction models, and improved accessibility.
Bio-Rad Laboratories has launched annexin V conjugated to eight StarBright Dyes to enhance apoptosis detection in flow cytometry.
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Quest Diagnostics' self-collection service for genital tract infection testing offers greater access to care at its patient service centers.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
FormaPath unveiled a new automated tissue visualization system developed in collaboration with Mayo Clinic's Advanced Diagnostics Laboratory.Â
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.